The exchange of off-label information and the sharing of scientific evidence can sometimes have important public health benefits.

Politicians wage broad wars on medicine to claim thin strips of ideological terrain. This would be good political theater if there weren't so many human victims.

Rigid adherence to restrictions on the exchange of off-label informationleads to failureto recognize that the sharing of scientific evidence can have important public health benefits.

Politicians wage broad wars on medicine to claim thin strips of ideological terrain. This would be good political theater if there weren't so many human victims.

The United States has the best cancer-survival rates in the world. Why would we import policies that would undo our progress?

Could regulations restricting the use of certain drugs curb U.S. cancer survival rates?

Two recent experimental drugs demonstrate that new scientific principles are faster becoming superior medicines, but bad government policies threaten to reverse this trend.

John Kerry's plan for lowering U.S. health care costsincludes the importation of European and Canadian drugs. But Americans may not like what they would get under this arrangement.